Clinical Trial Update: Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter [Phase 1]

View source ↗

Summary

A Phase 1 multiple-dose pediatric study of apixaban for venous thromboembolism in children with an indwelling central venous catheter was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Venous Thromboembolism | Phase 1 | Status: TERMINATED